Form 8-K OMNIVISION TECHNOLOGIES For: Jul 23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
July 23, 2015
OMNIVISION TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
000-29939 |
|
77-0401990 |
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer |
4275 Burton Drive
Santa Clara, California 95054
(Address of principal executive offices, including zip code)
(408) 567-3000
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 5 Corporate Governance and Management
Item 5.07 Submission of Matters to a Vote of Security Holders
On July 23, 2015, OmniVision Technologies, Inc. (OmniVision) held a Special Meeting of Stockholders (the Special Meeting). At the Special Meeting, the stockholders of OmniVision voted on the following matters (as described in detail in OmniVisions definitive proxy statement filed with the Securities and Exchange Commission on June 10, 2015, as supplemented on July 9, 2015):
Proposal One Adoption of the Merger Agreement. The stockholders of OmniVision cast their votes on and approved the adoption of the Agreement and Plan of Merger, dated as of April 30, 2015, by and among OmniVision, Seagull International Limited and Seagull Acquisition Corporation, as it may be amended from time to time (the Merger Agreement) as follows:
FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTES |
|
37,752,638 |
|
433,879 |
|
690,445 |
|
0 |
|
Proposal Two Adjournment of the Special Meeting. The stockholders of OmniVision cast their votes on and approved the proposal to adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting as follows:
FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTES |
|
34,712,635 |
|
3,472,878 |
|
691,449 |
|
0 |
|
Proposal Three Advisory Vote on Executive Compensation. The stockholders of OmniVision cast their votes on and approved, by non-binding, advisory vote, the payment of compensation that will or may become payable by OmniVision to its named executive officers in connection with the merger of Seagull Acquisition Corporation with and into OmniVision, with OmniVision continuing as the surviving corporation and as a wholly owned subsidiary of Seagull International Limited, as follows:
FOR |
|
AGAINST |
|
ABSTAIN |
|
BROKER NON-VOTES |
|
36,241,007 |
|
1,788,694 |
|
847,261 |
|
0 |
|
Section 8 Other Events
Item 8.01 Other Events
In connection with the completion of the Special Meeting disclosed under Item 5.07 of this report, on July 24, 2015, OmniVision issued a press release announcing that, at the Special Meeting, the stockholders of OmniVision voted to approve the adoption of the Merger Agreement and certain related matters. A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.
Section 9 Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) |
Exhibits. |
Exhibit |
|
Description |
99.1 |
|
Press Release of OmniVision Technologies, Inc., dated July 24, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: July 24, 2015 |
|
OMNIVISION TECHNOLOGIES, INC. |
|
|
|
|
By: |
/s/ Y. VICKY CHOU |
|
|
Y. Vicky Chou |
|
|
Senior Vice President of Global Management and General Counsel |
EXHIBIT INDEX
Exhibit |
|
Description |
99.1 |
|
Press Release of OmniVision Technologies, Inc., dated July 24, 2015. |
Exhibit 99.1
OMNIVISIONS STOCKHOLDERS APPROVE ADOPTION OF MERGER AGREEMENT WITH HUA CAPITAL MANAGEMENT, CITIC CAPITAL AND GOLDSTONE INVESTMENT
SANTA CLARA, Calif., July 24, 2015 OmniVision Technologies, Inc. (Nasdaq: OVTI) (OmniVision), a leading developer of advanced digital imaging solutions, announced that its stockholders approved the adoption of the Agreement and Plan of Merger, dated as of April 30, 2015, by and among OmniVision, Seagull International Limited and Seagull Acquisition Corporation, as it may be amended from time to time (the Merger Agreement), at its special meeting of stockholders held on July 23, 2015. Seagull International Limited and Seagull Acquisition Corporation are affiliates of a consortium composed of Hua Capital Management Co., Ltd., CITIC Capital Holdings Limited and Goldstone Investment Co., Ltd.
Based on the tabulation of the stockholder vote, approximately 97.1% of the total votes cast, which represents approximately 64.6% of the total shares outstanding as of the June 9, 2015 record date for the special meeting, were voted in favor of the adoption of the Merger Agreement.
Under the terms of the Merger Agreement, stockholders of OmniVision will receive $29.75 per share in cash, or a total of approximately $1.9 billion. The transaction, which is expected to close in the third or fourth fiscal quarter of fiscal year 2016, is subject to regulatory approvals, including antitrust review in the U.S. and the Peoples Republic of China, review and clearance by the Committee on Foreign Investment in the U.S., clearance or approval under applicable Taiwan law, and other customary closing conditions. In order to obtain clearance or approval under applicable Taiwan law, OmniVision will divest certain of its investments in Taiwan, including certain of its interests in a joint venture.
Stockholders of OmniVision also approved, by non-binding, advisory vote, the payment of compensation that will or may become payable by OmniVision to its named executive officers in connection with the transaction.
About OmniVision
OmniVision Technologies, Inc. is a leading developer of advanced digital imaging solutions. Its CameraChip and CameraCubeChip products are highly integrated, single-chip CMOS image sensors for consumer and commercial applications, including mobile phones, tablets and entertainment devices, notebooks and webcams, security and surveillance systems, digital still and video cameras, automotive and medical imaging systems. Additional information is available at www.ovt.com.
Forward-Looking Statements
The matters discussed herein, including in any exhibits hereto, may contain forward-looking statements that are subject to risks and uncertainties. You can typically identify forward-looking statements by the use of forward-looking words, such as may, should, could, project, believe, anticipate, expect, estimate, continue, potential, plan, forecast and other words of similar import. Stockholders are cautioned that any forward-looking statements are not guarantees of future performance and may involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements. These risks and uncertainties could cause such forward-looking statements and OmniVisions actual results to differ materially. In evaluating these forward-looking statements, you should specifically consider various factors, including the factors listed in the Risk Factors section of OmniVisions Annual Report on Form 10-K for the fiscal year ended April 30, 2015 and its most recent quarterly reports filed on Form 10-Q. These factors may cause OmniVisions results to differ materially from any forward-looking statement. Forward-looking statements are only predictions and actual events or results may differ materially. OmniVision disclaims any obligation to update information contained in any forward-looking statement.
# # #
Contact Information
Investor Relations:
Mary McGowan
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
- ENDEAVOR ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of EDR and Encourages Investors to Contact the Firm
- Dicello Levitt LLP Announces Investor Class Action Lawsuit Filed Against QuidelOrtho Corp. f/k/a Quidel Corp. (NASDAQ: QDEL) And Lead Plaintiff Deadline
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!